The atheroprotective effects of estrogen in women are well recognized(
1), but the underlying mechanisms responsible are not well understood.
Blood vessel cells express the classic estrogen receptor, ER alpha (r
ef. 2-6), and are directly affected by estrogen, which inhibits the de
velopment of atherosclerotic and injury-induced vascular lesions(7,8).
We have generated mice in which the ER alpha gene is disrupted(9) and
have used a mouse model of carotid arterial injury to compare the eff
ects of estrogen on wild-type and estrogen receptor-deficient mice. In
creases in vascular medial area and smooth muscle cell proliferation w
ere quantified following vascular injury in ovariectomized mice treate
d with vehicle or with physiologic levels of 17 beta-estradiol. Supris
ingly, in both wild-type and estrogen receptor-deficient mice, 17 beta
-estradiol markedly inhibited to the same degree all measures of vascu
lar injury. These data demonstrate that estrogen inhibits vascular inj
ury by a novel mechanism that is independent of the classic estrogen r
eceptor, ER alpha.